Axatilimab Combined With Decitabine/Venetoclax for the Treatment of TP53-mutated AML
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE1
Clinical Trials Related to Venetoclax
Related studies linked through entity extraction aliases.
Pediatric-Inspired Regimen Combined With Venetoclax and Immunotherapy for Adult Ph-Negative Acute Lymphoblastic Leukemia
- Status
- RECRUITING
- Phase
- NA
Chemotherapy With Targeted-Immunotherapy for Newly Diagnosed Ph+ ALL
- Status
- RECRUITING
- Phase
- NA
Venetoclax, Azacitidine and Liposomal Mitoxantrone for Newly Diagnosed AML
- Status
- RECRUITING
- Phase
- NA
Aclarubicin Plus With Azacitidine and Venetoclax in the Treatment of Acute Myeloid Leukemia
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE1/PHASE2
Venetoclax, Azacitidine, and Mitoxantrone Hydrochloride Liposome Versus Idarubicin and Cytarabine in Newly Diagnosed AML
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE3
Inhibiting the Anti-apoptotic Factor, BCL-2, at the Time of ART Initiation to Promote Apoptosis of HIV-infected Cells and Restrict the Seeding of the HIV Reservoir (The INITIATE Study)
- Status
- RECRUITING
- Phase
- PHASE1
Azacytidine, Venetoclax Plus Minus Quizartinib for First Line Older/Unfit AML Patients (VENP-A-QUI)
- Status
- RECRUITING
- Phase
- PHASE3
VAH vs VA in Newly Diagnosed Elderly AML
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE3
ABL/JAK Inhibitors With Chemotherapy and Venetoclax for Ph-like ALL
- Status
- RECRUITING
- Phase
- NA
Assessing PI3K Gamma Inhibition With Azacitidine, Venetoclax and Eganelisib in Patients With Acute Myeloid Leukemia
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE1
Comparing Different Treatment Lengths for Venetoclax in Older People With Newly Diagnosed Acute Myeloid Leukemia (A MyeloMATCH Treatment Trial)
- Status
- RECRUITING
- Phase
- PHASE2
FLT3-ITD Targeted Therapy in Fit AML Patients
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2/PHASE3
Shortened Venetoclax Duration Based on Day 14 BM Blasts Versus Standard Therapy in Elderly or Frail Patients With AML Patients Treated With Azacitidine Plus Venetoclax
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE3
A Study of the Combination of Ivosidenib, Azacitidine, and Venetoclax Followed by Ivosidenib Alone in People With Acute Myeloid Leukemia
- Status
- RECRUITING
- Phase
- PHASE2
Study to Assess Change in Disease Activity of Oral Venetoclax in Adult Participants With Recurring Relapsed or Refractory (R/R) Waldenström Macroglobulinemia (WM)/Lymphoplasmacytic Lymphoma (LPL)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Adoptive T Cell Therapy With DC/AML Fusion Vaccine Plus Decitabine and Venetoclax in AML
- Status
- RECRUITING
- Phase
- PHASE1
Addition of Venetoclax to Combined Hematopoietic Stem Cell and Kidney Transplantation
- Status
- NOT_YET_RECRUITING
- Phase
- EARLY_PHASE1
Imetelstat Combinations in Relapsed AML
- Status
- RECRUITING
- Phase
- PHASE1
Efficacy and Safety of HMAs Combined With Venetoclax Versus HMAs Alone in ND Int-and H-risk MDS or CMML
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- N/A